Evaluating statewide HIV preexposure prophylaxis implementation using All-Payer Claims Data.

ABSTRACT:

Purpose

Preexposure prophylaxis (PrEP) in the form of daily emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) is effective for preventing HIV infection. Implementation has been limited by an inability to systematically evaluate uptake and use. All-Payer Claims Databases (APCDs) provide an opportunity to evaluate population-level PrEP implementation.

Methods

We used 2012-2017 data from Rhode Island's APCD and developed an algorithm to identify individuals prescribed FTC/TDF for PrEP. We describe PrEP implementation by patient demographics and provider type and mapped PrEP implementation across ZIP codes. We compared APCD data to electronic medical record data and comprehensive pharmaceutical claims data (AIDSVu.org).

Results

The Rhode Island APCD represented ap

SUBMITTER: Raifman J 

PROVIDER: S-EPMC7252205 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature